J. Safra Sarasin Holding AG

Position in VRTX — Vertex Pharmaceuticals Inc / Ma

CIK 1890222 BASEL, V8

Position in VRTX

as of Mar 31, 2026 · filed May 4, 2026 Compact

Position Value

$1,873,235

+$513,155 QoQ

Shares Held

4,195

+39.8% QoQ

Ownership

0.002%

of shares outstanding

% of Portfolio

0.03%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2024

8 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

J. Safra Sarasin Holding AG holds $32,968,666 across 16 Biotechnology names. VRTX ranks #5 (5.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	INSM	INSMED Inc	93,181	$15,236,957
2	INCY	Incyte Corp	30,341	$2,855,694
3	BMRN	Biomarin Pharmaceutical Inc	43,719	$2,469,686
4	RVMD	Revolution Medicines, Inc.	21,001	$2,042,347
5	VRTX	Vertex Pharmaceuticals Inc / Ma This page	4,195	$1,873,235
6	VRDN	Viridian Therapeutics, Inc.\DE	73,058	$1,429,014
7	MDGL	Madrigal Pharmaceuticals, Inc.	2,323	$1,216,020
8	ALNY	Alnylam Pharmaceuticals, Inc.	3,230	$1,068,710

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$1,873,235	4,195	+39.8%	Shares	Defined	2026-05-04
2025-12-31	$1,360,080	3,000	-21.6%	Shares	Defined	2026-01-15
2025-09-30	$1,498,806	3,827	+27.6%	Shares	Defined	2025-11-03
2025-06-30	$1,335,600	3,000	-24.0%	Shares	Defined	2025-07-21
2025-03-31	$1,913,099	3,946	-92.9%	Shares	Defined	2025-05-09
2024-12-31	$22,509,316	55,896	-7.1%	Shares	Defined	2025-02-14
2024-09-30	$27,970,840	60,142	-11.1%	Shares	Defined	2024-11-12
2024-06-30	$31,694,843	67,620	—	Shares	Defined	2024-07-30
No filing history on record for this holder in this stock.